Cargando…
The CD153 vaccine is a senotherapeutic option for preventing the accumulation of senescent T cells in mice
Senotherapy targeting for senescent cells is designed to attenuate age-related dysfunction. Senescent T cells, defined as CD4(+) CD44(high) CD62L(low) PD-1(+) CD153(+) cells, accumulate in visceral adipose tissues (VAT) in obese individuals. Here, we show the long-lasting effect of using CD153 vacci...
Autores principales: | Yoshida, Shota, Nakagami, Hironori, Hayashi, Hiroki, Ikeda, Yuka, Sun, Jiao, Tenma, Akiko, Tomioka, Hideki, Kawano, Tomohiro, Shimamura, Munehisa, Morishita, Ryuichi, Rakugi, Hiromi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235045/ https://www.ncbi.nlm.nih.gov/pubmed/32424156 http://dx.doi.org/10.1038/s41467-020-16347-w |
Ejemplares similares
-
AJP001, a novel helper T‐cell epitope, induces a humoral immune response with activation of innate immunity when included in a peptide vaccine
por: Tenma, Akiko, et al.
Publicado: (2019) -
A novel angiotensin II peptide vaccine without an adjuvant in mice
por: Nakamaru, Ryo, et al.
Publicado: (2021) -
Development of an IL-17A DNA Vaccine to Treat Systemic Lupus Erythematosus in Mice
por: Koriyama, Hiroshi, et al.
Publicado: (2020) -
Preventative effects of the partial RANKL peptide MHP1-AcN in a mouse model of imiquimod-induced psoriasis
por: Ju, Nan, et al.
Publicado: (2019) -
Therapeutic vaccine for chronic diseases after the COVID-19 Era
por: Nakagami, Hironori, et al.
Publicado: (2021)